Format

Send to

Choose Destination
BMC Nephrol. 2016 Jul 29;17(1):104. doi: 10.1186/s12882-016-0322-7.

The role of plasma exchange in treating post-transplant focal segmental glomerulosclerosis: A systematic review and meta-analysis of 77 case-reports and case-series.

Author information

1
Division of Nephrology, Department of Medicine, Western University, London, Canada.
2
Department of Medicine, King Abdulaziz University Hospital, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia.
3
Victoria Hospital, 800 Commissioners Road East, A2-343, London, ON, Canada, N6A 5W9.
4
Department of Epidemiology and Biostatistics, Western University, London, Canada.
5
Kidney Clinical Research Unit, London Health Sciences Centre, 339 Windermere Road, London, ON, Canada, N6A 5A5.
6
Division of Nephrology, Department of Medicine, Western University, London, Canada. William.Clark@lhsc.on.ca.
7
Kidney Clinical Research Unit, London Health Sciences Centre, 339 Windermere Road, London, ON, Canada, N6A 5A5. William.Clark@lhsc.on.ca.
8
Victoria Hospital, 800 Commissioners Road East, A2-343, London, ON, Canada, N6A 5W9. William.Clark@lhsc.on.ca.

Abstract

BACKGROUND:

Evidence on the role of plasma exchange for treating recurrent post-transplant focal segmental glomerulosclerosis (FSGS) comes largely from individual cases and uncontrolled series. We conducted a systematic review and meta-analysis to estimate the remission rate after treatment with plasma exchange, and to determine if remission varied with patient or treatment characteristics.

METHODS:

We searched MEDLINE, EMBASE, Science Citation Index Expanded, and the Conference Proceedings Citation Index (Science and BIOSIS) for studies of patients with post-transplant recurrent FSGS who were treated with plasma exchange after recurrence (1950-2012). Of 678 studies screened, 77 met our inclusion criteria: 34 case reports (45 patients) and 43 case series (378 patients). We extracted patient-level data from each study and used random-effects models to calculate remission, defined as proteinuria <3.5 g/day (partial) or <0.5 g/day (complete).

RESULTS:

The overall remission rate in 423 patients with outcome data was 71 % (95 % CI: 66 % to 75 %). In 235 patients with data on age, remission was similar for adults and children: 69.1 % (95 % CI: 59.6 % to 77.2 %) and 70.2 % (95 % CI: 61.1 % to 77.9 %). Males were more likely to achieve remission (OR = 2.85; 95 % CI: 1.44 to 5.62) and patients treated within 2 weeks of recurrence showed a trend towards higher likelihood of remission (OR = 2.16; 95 % CI: 0.93 to 5.01). Proteinuria >7 g/day at recurrence was inversely associated with remission (OR = 0.43; 95 % CI: 0.19 to 0.97). Age and type of kidney transplant (living vs. deceased) did not associate with remission.

CONCLUSION:

In this systematic review of patients with recurrent post-transplant FSGS, 71 % of patients achieved full or partial remission after treatment with plasma exchange; however, extensive missing data and lack of a control group limit any conclusions on causality.

KEYWORDS:

Focal segmental glomerulosclerosis; Kidney transplantation; Plasma exchange; Plasmapheresis; Systematic review

PMID:
27473582
PMCID:
PMC4966699
DOI:
10.1186/s12882-016-0322-7
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center